TITLE

Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis

AUTHOR(S)
Molina-Molina, M.; Serrano-Mollar, A.; Bulbena, O.; Fernandez-Zabalegui, I.; Closa, D.; Marin-Argueclas, A.; Torrego, A.; Mullol, J.; Picado, C.; Xaubet, A.
PUB. DATE
July 2006
SOURCE
Thorax;Jul2006, Vol. 61 Issue 7, p604
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The angiotensin system has a role in the pathogenesis of pulmonary fibrosis. This study examines the antifibrotic effect of losartan, an angiotensin II type 1 receptor antagonist, in bleomycin induced lung fibrosis and its possible implication in the regulation of prostaglandin E2 (PGE2) synthesis and cyclooxygenase-2 (COX-2) expression. Methods: Rats were given a single intratracheal instillation of bleomycin (2.5 U/kg). Losartan (50 mg/kg/day) was administrated orally starting one day before induction of lung fibrosis and continuing to the conclusion of each experiment. Results: Losartan reduced the inflammation induced by bleomycin, as indicated by lower myeloperoxidase activity and protein content in the bronchoalveolar lavage fluid. Collagen deposition induced by bleomycin was inhibited by losartan, as shown by a reduction in the hydroxyproline content and the amelioration of morphological changes. PGE2 levels were lower in fibrotic lungs than in normal lungs. Losartan significantly increased PGE2 levels at both 3 and 15 days. A reduction in COX-2 expression by bleomycin was seen at 3 days which was relieved by losartan. Conclusions: The antifibrotic effect of losartan appears to be mediated by its ability to stimulate the production of PGE2. Losartan, which is already widely used clinically, could be assessed as a new treatment in lung fibrosis.
ACCESSION #
21715228

 

Related Articles

  • Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice. Langenbach, Shenna Y.; Wheaton, Ben J.; Fernandes, Darren J.; Jones, Catherine; Sutherland, Tara E.; Wraith, Bronwyn C.; Harris, Trudi; Schuliga, Michael J.; McLean, Catriona; Stewart, Alastair G. // Canadian Journal of Physiology & Pharmacology;Jul2007, Vol. 85 Issue 7, p727 

    Bleomycin-induced lung fibrosis in mice reproduces some key features of pulmonary fibrosis in humans including alveolar inflammation, myofibroblast proliferation, and collagen deposition. Glucocorticoids have been used as first-line therapy for the treatment of lung fibrosis, although their...

  • Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Otsuka M; Takahashi H; Shiratori M; Chiba H; Abe S // Thorax;Jan2004, Vol. 59 Issue 1, p31 

    BACKGROUND: Signalling of angiotensin II via angiotensin II type 1 receptor (AT1) promotes cardiac and renal fibrosis, but its role in lung fibrosis is little understood. Using a rat bleomycin (BLM) induced model of pulmonary fibrosis, we examined the expression of AT1 in the lung and the effect...

  • Altered prostanoid production by fibroblasts cultured from the lungs of human subjects with idiopathic pulmonary fibrosis. Cruz-Gervis, Roberto; Stecenko, Arlene A.; Dworski, Ryszard; Lane, Kirk B.; Loyd, James E.; Pierson, Richard; King, Gayle; Brigham, Kenneth L. // Respiratory Research;2002, Vol. 3, p17 

    Background: Prostanoids are known to participate in the process of fibrogenesis. Because lung fibroblasts produce prostanoids and are believed to play a central role in the pathogenesis of idiopathic pulmonary fibrosis (IPF), we hypothesized that fibroblasts (HF) cultured from the...

  • Effects of IS-741, a Synthetic Anti-Inflammatory Agent, on Bleomycin-Induced Lung Injury in Mice. Shimaoka, Yuichi; Tajima, Shunji; Fujimori, Fumio; Yamabayashi, Cristiane; Moriyama, Hiroshi; Terada, Masaki; Takada, Toshinori; Suzuki, Eiichi; Bando, Masashi; Sugiyama, Yukihiko; Narita, Ichiei // Lung;Sep/Oct2009, Vol. 187 Issue 5, p331 

    Bleomycin (BLM)-induced lung injury consists of excessive inflammatory cell infiltration and fibrosis. IS-741 has been reported to be an anti-inflammatory drug through an inhibitory action on cell adhesion. In this study we investigated whether IS-741 could inhibit the progression of pulmonary...

  • Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions. Haston, C. K.; Tomko, T. G.; Godin, N.; Kerckhoff, L.; Hallett, M. T. // Journal of Medical Genetics;Jun2005, Vol. 42 Issue 6, p464 

    Background: Pulmonary fibrosis is a complex disease for which the predisposing genetic variants remain unknown. In a prior study, susceptibility to bleomycin induced pulmonary fibrosis was mapped to loci Blmpf1 and Blmpf2 on chromosomes 17 and 11, respectively, in a C57BL/6J (B6, susceptible)...

  • EFFECTS OF MATRINE ON JAK-STAT SIGNALING TRANSDUCTION PATHWAYS IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS. Xiuqin Ma; Ruhua Chen; Xiufang Liu; Jin Xie; Keyun Si; Lirong Duan // African Journal of Traditional, Complementary & Alternative Medi;2013, Vol. 10 Issue 3, p442 

    aims to investigate the effects of matrine on the JAK-STAT signaling transduction pathways in bleomycin (BLM)-induced pulmonary fibrosis (PF) and to explore its action mechanism. A total of 72 male C57BL/6 mice were randomized into the control, model, and treatment groups. PF models were...

  • Reactions of the blood system and stem cells in bleomycin-induced model of lung fibrosis. Dygai, A.; Skurikhin, E.; Andreeva, T.; Ermolaeva, L.; Khmelevskaya, E.; Pershina, O.; Krupin, V.; Reztsova, A.; Stepanova, I.; Goldberg, V. // Bulletin of Experimental Biology & Medicine;Decv2011, Vol. 152 Issue 2, p173 

    On the model of toxic diffuse pulmonary fibrosis induced by intratracheal administration of bleomycin, we studied reactions of the blood system, content of stem cells, committed hemopoietic and stromal progenitor cells in the bone marrow, spleen and peripheral blood of C57Bl/6 mice. It was shown...

  • Bleomycin.  // Reactions Weekly;8/23/2008, Issue 1216, p10 

    The article describes the case of a 27-year-old pregnant woman who developed fatal pulmonary fibrosis after receiving bleomycin. The pregnant patient was diagnosed at 16 weeks' gestation with an endodermal sinus tumor of the left ovary. One month after the last cycle of antineoplastic therapy...

  • Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis. Srivastava, Mrigank; Steinwede, Kathrin; Kiviranta, Riku; Morko, Jukka; Hoymann, Heinz-Gerd; Länger, Florian; Buhling, Frank; Welte, Tobias; Maus, Ulrich A. // Respiratory Research;2008, Vol. 9, Special section p1 

    Background: Lung fibrosis is a devastating pulmonary disorder characterized by alveolar epithelial injury, extracellular matrix deposition and scar tissue formation. Due to its potent collagenolytic activity, cathepsin K, a lysosomal cysteine protease is an interesting target molecule with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics